We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Mucuna Pruriens vs NAC: NAC has the stronger overall evidence (6 vs 6/10); they're alternatives for male fertility — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
NAC wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
1 of 1 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
5 of 6 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Mucuna Pruriens and NAC have evidence — compare verdict strength side-by-side.
200-500mg extract (standardized to 15-20% L-DOPA) (a typical label dose, not the dose used in the cited trials, which gave 5 g a day of whole seed powder, or single doses of 15 to 30 g in Parkinson's disease)
Morning or early afternoon, On empty stomach or with protein
Standardized extract (15-20% L-DOPA)
600-1800mg daily
Away from food, Split into 2-3 doses
NAC capsules or powder
and 2 more not shown
1-4 weeks
8-12 weeks
4-8 weeks
4-8 weeks
2-4 weeks
1-2 weeks
Immediate
Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives
CNS neuroscience & therapeutics (2025) · Systematic review
Systematic review of preclinical studies and clinical trials from 2023 to 2025 comparing levodopa with plant compounds in Parkinson's disease.
Phytochemicals in Parkinson's Disease: a Pathway to Neuroprotection and Personalized Medicine
Cell biochemistry and biophysics (2025) · Review
This review provides a comprehensive overview of the neuroprotective potential of phytochemicals in PD management, examining the mechanisms underlying PD pathogenesis and emphasizing neuroprotection.
Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases
Phytotherapy research : PTR (2023) · Review
Alkaloids, amino acids, anthocyanidins, flavonoids, glucosinolates, isoflavonoids, phenolic acids, polyphenolics, and triterpenoids are among the bioactive metabolites pocessing an impressive ACE inhibitory activity.
Efficacy of N-Acetylcysteine in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Nutrients (2025) · Meta analysis · n=2515
Twenty-two studies (n = 2515) were included.
Efficacy of N-acetylcysteine for patients with depression: An updated systematic review and meta-analysis
General hospital psychiatry (2024) · Meta analysis · n=904
Our findings indicate that adjunctive NAC can ameliorate depressive symptoms in patients with psychiatric problems, particularly bipolar disorder.
N-acetylcysteine as a treatment for substance use cravings: A meta-analysis
Addiction biology (2024) · Meta analysis · n=623
The most targeted substance in the clinical trials was alcohol (3/9; 33.3%), followed by tobacco (2/9; 22.2%) and multiple substances (2/9; 22.2%).
Three pooled analyses tie a dose to a result. A meta-analysis of 13 studies in 4,155 patients (PMID 26324807) found fewer exacerbations with NAC (RR 0.75), with 600 mg a day sufficient in chronic bronchitis without airway obstruction and doses above 600 mg (it recommends 1,200 mg or more) also effective in spirometry-confirmed COPD (RR 0.75). Adverse reactions were not dose-dependent. A meta-analysis of 775 patients on NAC and 789 on placebo (PMID 31598901) found RR 0.81 and says under 1,200 mg a day for at least 3 months seems effective. A network meta-analysis of 7 trials in 2,753 COPD patients (PMID 31133026) at 1,200 mg a day found NAC shortened exacerbations but, unlike erdosteine, did not reduce the risk of having one, and it was well tolerated. No source shows a larger effect at 1,200 mg than at 600 mg, so the curve stays flat. 1,200 mg is the highest dose these sources report.
AI-estimated from published studies. Interpret as directional guidance.
NAC has a higher evidence score (6/10 vs 6/10) and wins in 2 of 3 categories.
For male fertility, NAC has a higher relevance score (82 vs 75).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
Weight loss is the real treatment; vitamin E/omega-3 have some evidence, milk thistle modest, TUDCA thin.
Folate is essential; inositol + CoQ10 are the best bets — but conception evidence is limited.
Inositol (40:1), and the supporting cast for insulin resistance, cycles & fertility.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.